DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Research & Reports

Searching in Medtech (467)

Global Markets for Therapeutic Botulinum Toxin 2009

Global Markets for Therapeutic Botulinum Toxin 2009

Thank you!

Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.

The global market for therapeutic botulinum toxin (BTX) will experience substantial growth through 2013 due to expanded indications of BTX products and both physicians' and patients' preference for this treatment. The entry of new competitors and growth of existing competitors into new geographies will alter the competitive landscape and enhance the need for marketing efforts, leading to greater awareness. Although competition from alternate treatments such as prescription drugs will limit the use of therapeutic BTX, the market will experience increasing revenues over the forecast period.

Report Highlights:

-Understand how approvals of new indications will raise procedure volumes and drive market growth through 2013.

-Assess the impact of new market entrants and existing competitors entering new geographies.

-Identify the fastest-growing market segments for future expansion.

-Recognize the most commonly performed BTX procedures based on incidence rates and patient demand.

  • Pub Date: November 2008

Request report

Related reports:
You may also be interested in: